TrialBJU international2022

Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trial.

Yasuyoshi Miyata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.